Accesswire

STOCKHOLM, SWEDEN / ACCESSWIRE / April 25, 2024 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) AlzeCure Pharma AB (publ) (FN STO:ALZCUR) today announced that its interim report for the period January - March 2024 is now available on the company's website: www.alzecurepharma.com/en/section/investors/financial-reports/

"The first quarter of 2024 was positive and active for AlzeCure Pharma. In our clinical Alzheimer's program, NeuroRestore ACD856, we presented new preclinical data... (continue reading...)

EASTLEIGH, UNITED KINGDOM / ACCESSWIRE / April 25, 2024 / i3 Energy plc (AIM:I3E)(TSX:ITE), an independent oil and gas company with assets and operations in the UK and Canada, is pleased to announce the Company's 2024 capital budget and production guidance. The Company will hold an investor webinar on Thursday 2 May 2024 at 12:00 pm BST including a Q&A session (details of which can be found below).

Highlights:

� 2024 Capital Budget

2024 Capital Budget of USD 50.9 million,... (continue reading...)

LONDON, UNITED KINGDOM / ACCESSWIRE / April 25, 2024 / The Company announces that on 24 April 2024 it purchased the following number of its ordinary shares of 20340/399 pence each through Goldman Sachs International ("GSI") on the London Stock Exchange in accordance with the authority granted by shareholders at the Company's Annual General Meeting on 5 May 2023 (the "Purchase"). The Purchase was effected pursuant to instructions issued by the Company on 20 February... (continue reading...)

LONDON, UNITED KINGDOM / ACCESSWIRE / April 25, 2024 / The Company announces that on 24 April 2024 it purchased the following number of its ordinary shares of 20340/399 pence each through Goldman Sachs International ("GSI") on the London Stock Exchange in accordance with the authority granted by shareholders at the Company's Annual General Meeting on 5 May 2023 (the "Purchase"). The Purchase was effected pursuant to instructions issued by the Company on 20 February... (continue reading...)

Trading Update for the First Quarter ended 29 March 2024 & Interim Dividend Declaration

UXBRIDGE, UNITED KINGDOM / ACCESSWIRE / April 25, 2024 / Good start to the year, confidently reaffirming FY24 guidance

Q1 2024

Change vs 2023

Revenue

Volume (UC) [2]

Revenue per UC [1],[2],[3]

Comparable Volume [1]

Revenue per UC [1],[2],[3]

FXN [1],[3] Revenue

Revenue

Europe

�3,290m

582m

�5.62

(1.4)%

5.6%

4.0%

4.6%

APS

�1,175m

247m

�4.98

38.8%

(12.3)%

22.0%

16.5%

CCEP

�4,465m

829m

�5.43

7.9%

0.5%

8.4%

7.5%

Q1... (continue reading...)